structure of 1-(Tetrahydro-2H-pyran-2-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole

1-(Tetrahydro-2H-pyran-2-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole

CAS No.: 1003846-21-6
M. Wt: 278.155
M. Fa: C14H23BN2O3
InChI Key: YYSLAWXDXHVRHU-UHFFFAOYSA-N
Appearance: Off white solid

Names and Identifiers of 1003846-21-6

CAS Number

1003846-21-6

EC Number

817-729-2

MDL Number

MFCD16556148

IUPAC Name

1-(oxan-2-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole

InChI

InChI=1S/C14H23BN2O3/c1-13(2)14(3,4)20-15(19-13)11-9-16-17(10-11)12-7-5-6-8-18-12/h9-10,12H,5-8H2,1-4H3

InChIKey

YYSLAWXDXHVRHU-UHFFFAOYSA-N

Canonical SMILES

B1(OC(C(O1)(C)C)(C)C)C2=CN(N=C2)C3CCCCO3

UNSPSC Code

12352100

Physical and chemical properties of 1003846-21-6

Acidity coefficient

1.95±0.19(Predicted)

Boiling Point

413.8±35.0 °C at 760 mmHg

Density

1.2±0.1 g/cm3

Exact Mass

278.180176

Flash Point

204.1±25.9 °C

Index of Refraction

1.545

LogP

1.88140

Molecular Formula

C14H23BN2O3

Molecular Weight

278.155

PSA

45.51000

Storage condition

2~8℃

Vapour Pressure

0.0±0.9 mmHg at 25°C

Safety Information of 1003846-21-6

Pictograms

Signal Word

Warning

Safety Data Sheet

Supports customized editing of SDS information and downloading in PDF documents.

Applications of 1003846-21-6

The unique properties of 1-(tetrahydro-2H-pyran-2-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole lend themselves to several applications:

  • Drug development: Its potential biological activities make it a candidate for further exploration in pharmaceutical applications.
  • Material science: The compound's reactivity can be harnessed in the development of novel materials or catalysts.

Research into these areas is ongoing to fully exploit its capabilities.

Interaction Studies of 1003846-21-6

Interaction studies involving 1-(tetrahydro-2H-pyran-2-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole are crucial for understanding its behavior in biological systems and chemical environments. Preliminary studies suggest that:

  • The compound may interact with biomolecules such as proteins and nucleic acids through hydrogen bonding and hydrophobic interactions.
  • Its boron-containing structure may facilitate interactions with enzymes or receptors that recognize boron species.

These interactions could inform future research directions aimed at therapeutic applications.

Physical sample testing spectrum (NMR) of 1003846-21-6

Physical sample testing spectrum (NMR) of 1003846-21-6

Retrosynthesis analysis of 1003846-21-6

  • Route#1

    Cas:110-87-2
    Cas:269410-08-4
    Cas:1003846-21-6
  • Route#2

    Cas:73183-34-3
    Cas:1003846-21-6